These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20730857)

  • 1. Pattern of recurrence in patients with ruptured primary gastrointestinal stromal tumour.
    Hohenberger P; Ronellenfitsch U; Oladeji O; Pink D; Ströbel P; Wardelmann E; Reichardt P
    Br J Surg; 2010 Dec; 97(12):1854-9. PubMed ID: 20730857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
    Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
    Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours.
    Aparicio T; Boige V; Sabourin JC; Crenn P; Ducreux M; Le Cesne A; Bonvalot S
    Eur J Surg Oncol; 2004 Dec; 30(10):1098-103. PubMed ID: 15522557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
    Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
    Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastrointestinal stromal tumor (GIST)--medical rarities?].
    Predescu D; Gheorghe M; Predoiu I; Iosif C; Constantin A; Chiru F; Cociu L; Constantinoiu S
    Chirurgia (Bucur); 2010; 105(4):577-85. PubMed ID: 20941986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistopathological and molecular genetic features of a case in which gastrointestinal stromal tumor recurred five times.
    Inoue T; Suzuki T; Nakagawa K; Kurokawa Y; Satomi S; Moriya T; Sasano N; Sasano H
    Pathol Int; 2004 Mar; 54(3):196-200. PubMed ID: 14989743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audit of a series of 40 gastrointestinal stromal tumour cases.
    Hinz S; Pauser U; Egberts JH; Schafmayer C; Tepel J; Fändrich F
    Eur J Surg Oncol; 2006 Dec; 32(10):1125-9. PubMed ID: 16859873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and prognostic factors of primary gastric GIST following complete surgical resection: a single surgeon experience.
    Euanorasetr C
    J Med Assoc Thai; 2011 Jan; 94(1):55-64. PubMed ID: 21425729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Navigating risk stratification systems for the management of patients with GIST.
    Patel S
    Ann Surg Oncol; 2011 Jun; 18(6):1698-704. PubMed ID: 21213058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
    Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
    Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
    Liang YM; Li XH; Chen W
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
    Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
    Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
    Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An audit of surgical management of gastrointestinal stromal tumours (GIST).
    Bucher P; Egger JF; Gervaz P; Ris F; Weintraub D; Villiger P; Buhler LH; Morel P
    Eur J Surg Oncol; 2006 Apr; 32(3):310-4. PubMed ID: 16414236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A gastrointestinal stromal tumor of the stomach morphologically resembling a neurofibroma: demonstration of a novel platelet-derived growth factor receptor alpha exon 18 mutation.
    Liu T; Willmore-Payne C; Layfield LJ; Glasgow RE; Holden JA
    Hum Pathol; 2008 Dec; 39(12):1849-53. PubMed ID: 18657298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor size is a major determinant of recurrence in patients with resectable gastrointestinal stromal tumor.
    Hsu KH; Yang TM; Shan YS; Lin PW
    Am J Surg; 2007 Aug; 194(2):148-52. PubMed ID: 17618793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical management in metastatic gastrointestinal stromal tumor (GIST) patients after imatinib mesylate treatment.
    Yeh CN; Chen TW; Tseng JH; Liu YY; Wang SY; Tsai CY; Chiang KC; Hwang TL; Jan YY; Chen MF
    J Surg Oncol; 2010 Nov; 102(6):599-603. PubMed ID: 20976730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).
    Martín J; Poveda A; Llombart-Bosch A; Ramos R; López-Guerrero JA; García del Muro J; Maurel J; Calabuig S; Gutierrez A; González de Sande JL; Martínez J; De Juan A; Laínez N; Losa F; Alija V; Escudero P; Casado A; García P; Blanco R; Buesa JM;
    J Clin Oncol; 2005 Sep; 23(25):6190-8. PubMed ID: 16135486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies.
    Hassan I; You YN; Dozois EJ; Shayyan R; Smyrk TC; Okuno SH; Donohue JH
    Dis Colon Rectum; 2006 May; 49(5):609-15. PubMed ID: 16552495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.